ebook Munafa Stock Market Course + Intraday & FNO calls  

       

IONS NEWS why is Ionis Pharmaceuticals, Inc. price falling or rising

IONS NEWS reasons for why stock price of Ionis Pharmaceuticals, Inc. is falling or rising

IONS Ionis Pharmaceuticals is falling or rising technical reasons

Technical analysis forecast for Ionis Pharmaceuticals Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Ionis Pharmaceuticals IONS at this time. Stock is falling and might fall more.

It appears as if Ionis Pharmaceuticals IONS gave a large move recently.

Stock of Ionis Pharmaceuticals (IONS) is trading below an important moving average line, but it crossed this line recently, which means that it could show a small or a large recovery soon enough depending on its trend.

Although my analysis for Ionis Pharmaceuticals is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 75.9, for a target of 77.8 or 79.4

IONS Ionis Pharmaceuticals is falling or rising NEWS fundamental reasons

Sandip Agarwal on IT sector: Improved margins, but growth expectations need a reset Indian IT stocks saw a boost after a large-cap firm upgraded its FY26 revenue guidance. However, experts remain cautious, viewing the sector as mature with limited high-growth potential. While some see IT as a quasi-cash substitute for expensive sectors li - NEWS as on 2026-01-16 indiatimes.com

Why GLP-1 users are ditching injections and turning to other weight-loss methods - NEWS as on 2026-01-15 marketwatch.com

How to Invest in 2026: Growth, Valuations & Data Edge | The Golden Thumb Rule with Deepak Shenoy - NEWS as on 2026-01-14 indiatimes.com

Rupee slips, likely intervention cushions pressure from weak stocks, Asia FX The Indian rupee ?closed modestly weaker on Tuesday, ?weighed down by a fall in local stocks and regional ?currencies, while likely intervention by the central bank limited the currency's decline. - NEWS as on 2026-01-13 indiatimes.com

Why oil prices could rise as U.S.-Iran tensions swell - NEWS as on 2026-01-12 marketwatch.com

MeitY conducts routine stakeholder consultations on mobile security standards The Ministry of Electronics and Information Technology (MeitY) conducted routine stakeholder consultations on safety and security requirements on Sunday, maintaining continuous engagement with the industry on security standards. These structured discussion - NEWS as on 2026-01-12 indiatimes.com

Mutual fund SIP stoppage ratio rises to 85% in December even as contributions hit record Rs 30,002 crore Mutual fund SIP contributions hit a record Rs 30,002 crore in December, even as the SIP stoppage ratio climbed to 85%. AMFI data shows strong long-term investor participation, rising SIP AUM and expanding folio count despite market volatility. - NEWS as on 2026-01-10 indiatimes.com

Manappuram Finance shares tumble 10% on report of RBI objections to Bain Capital deal Manappuram Finance shares fell 10% after a Reuters report said the RBI has objected to Bain Capital’s plan to acquire a controlling stake. Heavy volumes marked the sell-off as investors assessed regulatory risks surrounding the proposed investment. - NEWS as on 2026-01-09 indiatimes.com

2 top stock recommendations by Rahul Sharma Indian equity markets experienced sharp profit-taking, with the Nifty slipping below the crucial 26,000 mark and breaching 25,950, signaling heightened near-term volatility. Experts anticipate this uncertainty to persist until early next week, awaiting U.S - NEWS as on 2026-01-08 indiatimes.com

3 Stocks With Analyst Revisions That Could Drive Earnings Surprises The fourth quarter earnings season will begin in mid-January. Earnings growth is one of the most reliable signals of future stock price growth. However, many investors get caught unaware after a company posts strong results. That can be frustrating, as the - NEWS as on 2026-01-08 nasdaq.com

Client Associates sets Sensex's 2026 target at 93,918; sees elevated valuations, earnings moderation as headwinds Client Associates has set a December 2026 Sensex target of 93,918, implying 10% annual growth, while cautioning investors about elevated valuations and near-term earnings moderation, and highlighting gold and silver as strategic allocations amid global unc - NEWS as on 2026-01-07 indiatimes.com

Monthly SIP inflows double in three years as equity valuations stay elevated Indian savers are increasingly favoring Systematic Investment Plans (SIPs), with average monthly gross inflows more than doubling to ?28,202 crore in FY26. This surge, driven by robust equity fund returns and a preference for disciplined investing over lum - NEWS as on 2026-01-06 indiatimes.com

Commodity Radar: US-Venezuela tensions lift gold, but charts signal consolidation. Buy or sell? Domestic gold prices jumped 1.8% or over Rs 2,400 per 10 grams on Monday, driven by safe-haven demand amid the US–Venezuela conflict. COMEX gold rose 2.3% intraday, while MCX February futures traded near Rs 1,37,671, though prices remain below record highs - NEWS as on 2026-01-05 indiatimes.com

RBI lets existing non-compliant related-party transactions continue till maturity The Reserve Bank of India has issued new rules for related party transactions. Existing deals not meeting the new standards can continue until they mature. Equity investments are not included in these new directions. The RBI aims to prevent conflicts of in - NEWS as on 2026-01-05 indiatimes.com

Is the Options Market Predicting a Spike in EOG Resources Stock? Investors need to pay close attention to EOG Resources stock based on the movements in the options market lately. - NEWS as on 2026-01-04 nasdaq.com

2 top stock recommendations from Dharmesh Shah Indian markets begin 2026 with significant gains. The Bank Nifty has surpassed 60,000, and the broader Nifty is targeting 26,700. Market strategist Dharmesh Shah anticipates continued upward movement. Key stock recommendations include L&T and Adani Por - NEWS as on 2026-01-02 indiatimes.com

Sandeep Tandon on valuations, IPO hype and investor discipline Investors faced significant psychological challenges in 2025 due to extreme valuations and uneven market gains. Sandeep Tandon, CIO of Quant Mutual Fund, highlights the importance of emotional control and avoiding the trap of chasing momentum. While 2025 s - NEWS as on 2026-01-01 indiatimes.com

Nimesulide banned: Govt puts a stop to manufacture, sale of all oral formulations containing the popular painkiller above 100 mg Nimesulide sale banned: The move follows recommendation by India’s top research body- Indian Council of Medical Research (ICMR). In it’s earlier report to the drug regulatory body it had ecommended a total ban on all formulations of ninrsulide above 100 mg - NEWS as on 2025-12-31 indiatimes.com

More announcements and NEWS

IONS Ionis Pharmaceuticals, Inc. current price & indicator signals

Moving Averages for Ionis Pharmaceuticals, Inc.

  • 5Day Average: 78.71
  • 12Day Average: 79.78
  • 20Day Average: 79.79
  • 50Day Average: 78.26
  • 100Day Average: 71.75
  • 150Day Average: 61.6
  • 200Day Average: 54.08

IONS Indicators & signals

Indicator MACD (12,26,9)

79.22, 79.23, 0.57
Indicator MACD is in negative zone

Indicator ADX (14)

20.66, 17.39, 26.45
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 53
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of IONS Ionis Pharmaceuticals, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
16 Fri Jan 2026 76.33 74.49 to 78.00 -1.14% 1.42 times
15 Thu Jan 2026 77.21 77.15 to 79.75 -2.1% 0.67 times
14 Wed Jan 2026 78.87 77.69 to 79.57 -0.77% 1.01 times
13 Tue Jan 2026 79.48 78.61 to 82.57 -2.67% 0.89 times
12 Mon Jan 2026 81.66 78.88 to 82.21 1.69% 0.74 times
09 Fri Jan 2026 80.30 79.30 to 83.23 -1.52% 1.26 times
08 Thu Jan 2026 81.54 79.94 to 83.79 -1.96% 0.97 times
07 Wed Jan 2026 83.17 82.40 to 86.15 2.06% 1.84 times
06 Tue Jan 2026 81.49 78.00 to 81.54 3.77% 1.26 times
05 Mon Jan 2026 78.53 76.08 to 79.42 -1.43% 0.69 times
02 Fri Jan 2026 79.67 78.02 to 80.21 0.71% 0.66 times
31 Wed Dec 2025 79.11 78.63 to 79.84 0.18% 0.52 times

Videos related to: IONS NEWS why is Ionis Pharmaceuticals, Inc. price falling or rising

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Hindi Basics How To Trade In FnO Futures Options Stock Market

IONS NEWS why is Ionis Pharmaceuticals, Inc. price falling or rising

 

Back to top